🔗 Share this article

Chancellor Rachel Reeves has announced she is preparing "targeted action to tackle household expense issues" in the forthcoming Budget.

In comments to media outlets, she noted that reducing inflation is a shared duty of both the government and the central bank.

The United Kingdom's price growth is projected to be the most elevated among the G7 industrialized countries this year and the following year.

Possible Energy Cost Interventions

It is understood the administration could intervene to reduce utility costs, for instance by cutting the current 5% level of VAT applied on energy.

An additional approach is to lower some of the government charges presently added to bills.

Budgetary Limitations and Analyst Expectations

The administration will receive the latest report from the independent fiscal watchdog, the Office for Budget Responsibility, on the start of the week, which will reveal how much room there is for such actions.

The expectation from the majority of experts is that Reeves will have to declare tax increases or spending cuts in order to fulfill her voluntary borrowing rules.

Earlier on Thursday, estimates indicated there was a £22 billion deficit for the chancellor to resolve, which is at the lower end of forecasts.

"It is a collective responsibility between the central bank and the administration to further reduce some of the causes of inflation," Reeves told reporters in the US capital, at the conferences of the IMF and global financial institution.

Revenue Pledges and International Issues

While much of the attention has been on likely tax rises, the chancellor said the latest figures from the fiscal watchdog had not changed her commitment to election pledges not to increase rates on earnings tax, VAT or National Insurance.

She attributed an "uncertain global environment" with growing geopolitical and trade tensions for the Budget revenue measures, probably to be focused on those "with the broadest shoulders."

Global Economic Disputes

Commenting on worries about the UK's trade ties with China she said: "Our security interests invariably take priority."

Last week's statement by China to tighten trade restrictions on rare earths and other resources that are crucial for high-technology manufacturing led US President Donald Trump to propose an extra 100% import tax on goods from China, raising the risk of an all-out trade war between the two economic giants.

The US Treasury Secretary described China's action "economic coercion" and "a global supply chain power grab."

Questioned on accepting the US offer to participate in its conflict with China, the Chancellor said she was "very concerned" by China's actions and urged the Chinese government "not to put up barriers and limit trade."

She said the decision was "bad for the world economy and generates additional challenges."

"It is my opinion there are sectors where we must confront China, but there are also important chances to trade with Chinese markets, including financial services and other areas of the economic system. We've got to get that balance correct."

The chancellor also affirmed she was collaborating with G7 counterparts "regarding our own critical minerals plan, so that we are more independent."

Health Service Drug Costs and Investment

The Chancellor also admitted that the cost the National Health Service pays for drugs could rise as a consequence of ongoing negotiations with the Trump administration and its pharmaceutical firms, in exchange for reduced taxes and capital.

A number of the world's largest pharmaceutical manufacturers have said recently that they are either delaying or abandoning investments in the UK, with some attributing the modest returns they are getting.

Recently, the government science advisor said the price the health service pays for medicines would need to rise to halt companies and pharmaceutical investment leaving the UK.

The Chancellor told media: "We have seen as a result of the payment system, that drug testing, new drugs have not been offered in the United Kingdom in the way that they are in other EU nations."

"Our aim is to make sure that patients receiving treatment from the NHS are able to receive the finest life-saving treatments in the globe. And so we are reviewing all of that, and... looking to secure increased capital into the UK."